NIMODIPINE (nimodipine) by PharmaIN is mechanism of action nimodipine is a calcium channel blocker. First approved in 2007.
Drug data last refreshed 19h ago
Mechanism of Action Nimodipine is a calcium channel blocker. The contractile processes of smooth muscle cells are dependent upon calcium ions, which enter these cells during depolarization as slow ionic transmembrane currents. Nimodipine inhibits calcium ion transfer into these cells and thus…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Acupuncture Combined With Nimodipine for Prevention of Post-stroke Dementia
Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1
Worked on NIMODIPINE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.